Eli Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says

Investing.com Gold reports: Eli Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says. Full body text was unavailable at ingest time, so this brief is based on headline context.